{"id":"https://genegraph.clinicalgenome.org/r/d530baa7-7c3d-47b6-82db-5006368c649fv1.0","type":"EvidenceStrengthAssertion","dc:description":"C3 was first reported in relation to autosomal dominant C3 Glomerulopathy (C3G) in 2010 (Martínez-Barricarte et al., PMID: 20852386). C3G is characterized by complement dysregulation occurring in the fluid phase and in the glomerular microenvironment (Smith et al., 2019, PMID: 30692664). The term C3G is inclusive of dense deposit disease (DDD) and C3 glomerulonephritis (C3GN). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found differences in phenotypic variability. Therefore, the following disease entities have been split into multiple disease entities, atypical hemolytic uremic syndrome (aHUS) (OMIM:612925) and C3G. The split curation for autosomal dominant aHUS has been curated separately. Seventeen variants (missense) that have been reported in 17 probands in 7 publications (PMIDs: 20852386, 21784901, 26283675, 26471127, 26895476, 29566171, 37615951) are included in this curation. The mechanism of pathogenicity is known to be gain of function (GOF), causing the score of variants’ functional evidence to be upgraded when in support of this mechanism. This gene-disease association is also supported by protein interaction with CFH, functional alteration demonstrated on alternative pathway (AP) hemolysis assay, and biochemical function involving C3 nephritic factor (C3NeF) (PMIDs: 379217, 9291131, 21784901). In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Complement-Mediated Kidney Diseases GCEP on the meeting date January 17, 2024 (SOP Version 10.1).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/d530baa7-7c3d-47b6-82db-5006368c649f","GCISnapshot":"https://genegraph.clinicalgenome.org/r/2e000b88-9487-46a6-830a-7a613152853d","calculatedEvidenceStrength":"Moderate","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/2e000b88-9487-46a6-830a-7a613152853d_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10069","date":"2024-03-29T21:23:41.200Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/2e000b88-9487-46a6-830a-7a613152853d_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10069","date":"2024-03-29T16:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2e000b88-9487-46a6-830a-7a613152853d_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2290a300-abc0-4b0e-b261-51bd10ffb28f","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2290a300-abc0-4b0e-b261-51bd10ffb28f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26895476","allele":{"id":"https://genegraph.clinicalgenome.org/r/2ad4f9f6-ed60-41c7-91ef-635c14f12293","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000064.4(C3):c.4552T>C (p.Cys1518Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA403612411"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/4a9aa1e6-eb22-4f2a-9ee2-901c79dd3675","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4a9aa1e6-eb22-4f2a-9ee2-901c79dd3675_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29566171","allele":{"id":"https://genegraph.clinicalgenome.org/r/fa1dffd0-2b64-4f5a-9689-7d68f926ad04","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000064.4(C3):c.3307G>C (p.Ala1103Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA403625939"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/4597b406-85c2-47a4-8457-fdeccb8527cd","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4597b406-85c2-47a4-8457-fdeccb8527cd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37615951","allele":{"id":"https://genegraph.clinicalgenome.org/r/2d9b28e2-c092-4c2d-8ed7-a833e9654e2c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000064.4(C3):c.2381T>G (p.Phe794Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA403635040"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/5569ab59-796a-4818-88f4-63e58304c088","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5569ab59-796a-4818-88f4-63e58304c088_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37615951","allele":{"id":"https://genegraph.clinicalgenome.org/r/cf54519d-f49d-4e00-ae52-9449addcb114","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000064.4(C3):c.647A>C (p.Gln216Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA403643176"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/87210767-ab0e-40e7-8331-fbceb08747b4","type":"EvidenceLine","dc:description":"The score of this variant was upgraded per expert consensus due to functional evidence supporting the GOF disease mechanism.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/87210767-ab0e-40e7-8331-fbceb08747b4_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"c.1775G>A p.R592Q: 22% binding to MCP of wild-type, leading to resistance to cleavage by factor I. (Frémeaux-Bacchi et al. 2008, PMID: 18796626)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/87210767-ab0e-40e7-8331-fbceb08747b4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29566171","allele":{"id":"https://genegraph.clinicalgenome.org/r/43b4c3b7-3ad4-4309-9ee1-69d7b354726f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000064.4(C3):c.1775G>A (p.Arg592Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA257691"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/f4292a26-d11d-49f3-a5b2-cf8af7dddb3c","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f4292a26-d11d-49f3-a5b2-cf8af7dddb3c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37615951","allele":{"id":"https://genegraph.clinicalgenome.org/r/7ba37b5d-2164-469c-9503-2c156bae701f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000064.4(C3):c.1769G>C (p.Gly590Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA9129337"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/4afe9371-076f-4beb-8cfb-d0c17f41e176","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4afe9371-076f-4beb-8cfb-d0c17f41e176_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37615951","allele":{"id":"https://genegraph.clinicalgenome.org/r/3be43e05-cbdc-4752-8919-1bd488a49614","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000064.4(C3):c.1277C>A (p.Thr426Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA403641228"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/6f027569-bde8-4c53-a83f-737cb08e51ef","type":"EvidenceLine","dc:description":"The score of this variant was upgraded per expert consensus due to functional evidence supporting the GOF disease mechanism.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6f027569-bde8-4c53-a83f-737cb08e51ef_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Significant decrease in FH binding.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/6f027569-bde8-4c53-a83f-737cb08e51ef_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37615951","allele":{"id":"https://genegraph.clinicalgenome.org/r/798b6684-0951-4a3c-8c48-74c8b0208a13","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000064.4(C3):c.3341C>T (p.Pro1114Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA403625640"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/e8cdee00-4da9-4502-9070-307264ca20da","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e8cdee00-4da9-4502-9070-307264ca20da_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26895476","allele":{"id":"https://genegraph.clinicalgenome.org/r/c4ec472f-a490-46cf-a117-7a50a2acbbfc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000064.4(C3):c.3908G>A (p.Arg1303His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA9128600"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/fc9b1db5-69c5-4a6b-98ba-32ea750b72b1","type":"EvidenceLine","dc:description":"The score of this variant was upgraded per expert consensus due to functional evidence supporting the GOF disease mechanism.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fc9b1db5-69c5-4a6b-98ba-32ea750b72b1_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The variant protein was resistant to cleavage by the AP C3-convertase. The variant C3-convertase was able to activate WT-C3, but showed 50% activity compared to WT AP C3-convertase. Var is resistant to activation by fI in the presence of fH.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/fc9b1db5-69c5-4a6b-98ba-32ea750b72b1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20852386","allele":{"id":"https://genegraph.clinicalgenome.org/r/c74337f2-7efc-4e62-8d78-4679991f84a1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000064.4(C3):c.2267T>C (p.Ile756Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA403635587"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/76facd00-3672-4342-9335-178167fb80f8","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/76facd00-3672-4342-9335-178167fb80f8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26895476","allele":{"id":"https://genegraph.clinicalgenome.org/r/351c69e7-1bb9-437e-a3c3-bf0a75c2868d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000064.4(C3):c.4873G>C (p.Asp1625His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA403610685"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/cdb3dc4f-3e32-4248-85bb-08225cd22ecf","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cdb3dc4f-3e32-4248-85bb-08225cd22ecf_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26283675","allele":{"id":"https://genegraph.clinicalgenome.org/r/369def12-cd7b-44ec-a90d-7285613ab6fd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000064.4(C3):c.1327G>T (p.Ala443Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA403641115"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/4e55142c-e3a2-4e92-a9e9-cd0ec9328d18","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4e55142c-e3a2-4e92-a9e9-cd0ec9328d18_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26895476","allele":{"id":"https://genegraph.clinicalgenome.org/r/b713e02d-d4d9-417f-a5ef-40df00fe018f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000064.4(C3):c.3959G>A (p.Arg1320Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA403618225"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/bac886bc-d6b6-482d-898e-84510cefbed9","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bac886bc-d6b6-482d-898e-84510cefbed9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21784901","allele":{"id":"https://genegraph.clinicalgenome.org/r/bd86d8f6-4191-4831-a694-504560b4658d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000064.4(C3):c.3608A>G (p.Lys1203Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA403620787"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/b0059f78-0889-4999-95b5-bcfcdecb671e","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b0059f78-0889-4999-95b5-bcfcdecb671e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26283675","allele":{"id":"https://genegraph.clinicalgenome.org/r/0d9e4122-64fd-4806-bceb-c3bff173dc63","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000064.4(C3):c.3953T>G (p.Leu1318Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA9128591"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/8e6ea833-183b-4f99-ae67-93df1556bd25","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8e6ea833-183b-4f99-ae67-93df1556bd25_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26283675","allele":{"id":"https://genegraph.clinicalgenome.org/r/03c150a3-66be-4fc2-bd65-337e361e6d77","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000064.4(C3):c.443G>A (p.Arg148Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10643358"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/1f9e9f25-3646-42b3-a245-3a8a8b1ba1bd","type":"EvidenceLine","dc:description":"The score of this variant was upgraded per expert consensus due to functional evidence supporting the GOF disease mechanism.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1f9e9f25-3646-42b3-a245-3a8a8b1ba1bd_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"In vitro, this C3 mutation exhibited decreased binding to CR1, resulting in less CR1-dependent cleavage of C3b by factor 1. Binding of mutant C3 to factor H was normal, but mutant C3 was less efficiently cleaved by factor I in the presence of factor H, leading to enhanced C3 fragment deposition on glomerular cells.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/1f9e9f25-3646-42b3-a245-3a8a8b1ba1bd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26471127","allele":{"id":"https://genegraph.clinicalgenome.org/r/c74337f2-7efc-4e62-8d78-4679991f84a1"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":5.3},{"id":"https://genegraph.clinicalgenome.org/r/2e000b88-9487-46a6-830a-7a613152853d_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2e000b88-9487-46a6-830a-7a613152853d_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/71507119-b2ef-4f49-9742-54c5e5991def","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9df80a0d-202c-410e-b7b7-e1cb74c4b2a1","type":"FunctionalAlteration","dc:description":"An AP hemolytic assay demonstrated that heterozygous risk factors of DDD (R102G and P314L) have lower APH50 values (higher AP activity) than controls homozygous for WT.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21784901","rdfs:label":"AP Hemolytic Assay"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2e000b88-9487-46a6-830a-7a613152853d_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/88f67ede-a947-4d62-b9cc-e7ee3b3e5606","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5d5fe7ae-befe-4767-8f9e-208fb8c15313","type":"Finding","dc:description":"Features of this phenotype are diagnosable in patients upon kidney biopsy.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/379217","rdfs:label":"C3NeF implication in disease","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f9e76595-84f3-4216-80c8-0b510f449c4c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eb78f3ac-6d7a-41f2-ac75-82c5a036ea86","type":"Finding","dc:description":"Using a microtitre plate assay, direct binding between complement factors I and H was demonstrated, and ligand blotting indicated that factor H interacts with the heavy chain of factor I. Direct C3(NH3)-factor I and C3(NH3)-factor H binding was characterized [where C3(NH3) is a form of C3 that is cleaved by factor I in the presence of factor H]. Both factor H and factor I interacted with both chains of C3(NH3) in ligand blotting.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9291131","rdfs:label":"CFH Interaction","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1.5}],"evidenceStrength":"Moderate","sequence":7995,"specifiedBy":"GeneValidityCriteria10","strengthScore":6.8,"subject":{"id":"https://genegraph.clinicalgenome.org/r/XjJX12xKepQ","type":"GeneValidityProposition","disease":"obo:MONDO_0013892","gene":"hgnc:1318","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_2e000b88-9487-46a6-830a-7a613152853d-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}